Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep37015.pdf
Reference39 articles.
1. Dienstag, J. L. Hepatitis B virus infection. The New England journal of medicine 359, 1486–1500, doi: 10.1056/NEJMra0801644 (2008).
2. Idilman, R. et al. Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naive chronic hepatitis B patients in the real-world setting. Journal of viral hepatitis 22, 504–510, doi: 10.1111/jvh.12358 (2015).
3. Chang, T. T. et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. The New England journal of medicine 354, 1001–1010, doi: 10.1056/NEJMoa051285 (2006).
4. Tsai, M. C. et al. A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice. The Journal of antimicrobial chemotherapy 67, 696–699, doi: 10.1093/jac/dkr495 (2012).
5. Batirel, A. et al. Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naive patients with chronic hepatitis B: a multicenter real-life study. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 28, 153–159, doi: 10.1016/j.ijid.2014.09.004 (2014).
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comprehensive analysis of CXCL10 and MIP-3a reveals their potential clinical application in hepatocellular carcinoma;Translational Oncology;2024-10
2. Detection technology and clinical applications of serum viral products of hepatitis B virus infection;Frontiers in Cellular and Infection Microbiology;2024-07-05
3. CXCL10 and its receptor in patients with chronic hepatitis B and their ability to predict HBeAg seroconversion during antiviral treatment with TDF;Journal of Medical Virology;2024-03
4. Profile and clinical significance of interferon gamma-inducible protein-10 (IP-10) and its receptor in patients with hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2023-08-20
5. Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma;Oncology;2023-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3